Pharmacologically active phenylpropanoids from Senra incana

Area of Science:

• Phytochemistry
• Pharmacology
• Natural Products Chemistry

Background:

• Senra incana is a plant species with potential medicinal properties.
• Inflammation is a complex biological response implicated in various diseases.
• Prostaglandin synthetase plays a key role in the inflammatory pathway.

Purpose of the Study:

• To isolate and identify compounds from Senra incana.
• To evaluate the inhibitory effects of isolated compounds on prostaglandin synthetase.
• To assess the anti-inflammatory activity of these compounds in vivo.

Main Methods:

• Aqueous extraction of Senra incana followed by isolation of four phenolic aldehydes: coniferaldehyde, scopoletin, sinapaldehyde, and syringaldehyde.
• In vitro inhibition assays of prostaglandin synthetase.
• In vivo topical anti-inflammatory assays using ethyl phenylpropiolate-induced rat ear edema.
• In vitro inhibition of electrically induced guinea pig ileum contractions.

Main Results:

• Coniferaldehyde, scopoletin, sinapaldehyde, and syringaldehyde were isolated from Senra incana.
• All four compounds demonstrated dose-dependent inhibition of prostaglandin synthetase, with coniferaldehyde and scopoletin being more potent than aspirin.
• Sinapaldehyde and scopoletin showed significant topical anti-inflammatory effects in rats at low doses (1-10 µg/ear).
• Coniferaldehyde and sinapaldehyde inhibited guinea pig ileum contractions, while syringaldehyde showed weak inhibition.

Conclusions:

• The isolated compounds from Senra incana possess significant anti-inflammatory properties.
• Coniferaldehyde and scopoletin exhibit potent inhibition of prostaglandin synthetase and anti-edema activity.
• Senra incana is a potential source of novel anti-inflammatory agents.